Biogen has made Medidata Rave its primary clinical trial technology platform, continuing the shift in power in the eClinical market.

Bioz has exited stealth with funding from 5AM Ventures and a platform it sees as taking some of the drudgery and guesswork out of sourcing research products.

HHS has set up a challenge to identify ways in which blockchain can support privacy, security and scalability in health IT and research data.

GlaxoSmithKline has set up a rheumatoid arthritis clinical trial running on Apple’s ResearchKit framework.

The National Cancer Institute has joined with three top European research institutions to create a globally accessible repository of 1,000 cancer cell models.

A team at Cincinnati Children's Hospital Medical Center has created a tool to improve analysis of adverse event data gathered by FDA.

Serialization software player Adents has wrapped up a $13 million round to expand its partnership program in the U.S. and break into new markets.

Siemens Venture Capital has invested in Riffyn, a developer of R&D design software that is weeks away from introducing its first commercial product.